#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

News

medicina_zena_zily_tromboza_nohy_doktor_vysetreni

A Brief History of Deep Vein Thrombosis Treatment – From Antiquity to the Present

4. 3. 2020 Source: Prevention of Thrombosis in Surgery

Deep vein thrombosis is among the common diseases that have accompanied humanity since its inception. Due to the low specificity of its clinical presentation (in contrast to, for example, varicose veins of the lower limbs), however, the disease long went undescribed in literature. The first descriptions of deep vein thrombosis did not appear until the Middle Ages – and from that moment, the gradual development of its treatment began. We offer you a brief but remarkable historical excursion in three stages.

operace_kolene

Current Recommendations of the American Society of Hematology for the Prevention of Thromboembolic Disease and Duration of Prophylaxis in Patients Undergoing Major Surgery

At the end of 2019, new recommendations were published by the American Society of Hematology (ASH)…
4. 3. 2020 Source: Prevention of Thrombosis in Surgery
Úspora pro pojištěnce

More Patients Will Now Have Access to Incontinence Aids

Since December of last year, new rules have been in effect for the prescription of medical aids…
3. 3. 2020 Source: Incontinence
infekce

Assessment of Infection Risk in Patients with Multiple Sclerosis Treated with Various DMDs

Although the increased risk of infections with some disease-modifying drugs (DMDs) is known, we…
3. 3. 2020 Source: Multiple Sclerosis
cukrovka, diabetes

Effects of Telmisartan on Vascular Endothelial Functions, Inflammation Parameters, and Insulin Resistance in Patients with CHD and DM

Patients with coronary heart disease (CHD) and diabetes mellitus (DM) often have dysfunctional…
2. 3. 2020 Source: Sartans in the Treatment of Hypertension
Ledviny a diagnóza

Metabolic Effect of Telmisartan and Candesartan in Kidney Transplant Patients

Increasing cardiovascular risk from complex causes warrants a comprehensive intervention. A…
2. 3. 2020 Source: Sartans in the Treatment of Hypertension

Favorable effect of linagliptin on renal endothelial functions in patients with type 2 diabetes mellitus

Diabetic nephropathy is the cause of up to 50% of cases of end-stage chronic kidney disease. The main...
1. 3. 2020 Source: Diabetes

Monitoring Limits in Prescribing Incontinence Aids is Essential

The amendment to the Public Health Insurance Act, which came into effect in December 2019, brought…
29. 2. 2020 Source: Incontinence
Starší žena vybírá inkontinenční pomůcku

The Patient Will Feel Comfortable Only with a Properly Chosen Absorption Aid

While before the approval of the amendment to the Public Health Insurance Act, it was possible to…
27. 2. 2020 Source: Incontinence

Initiation of Sacubitril/Valsartan After Acute Decompensation of Chronic Heart Failure: The Sooner, the Better

The recently published analysis of data from the extended open-label follow-up of participants in…
27. 2. 2020 Source: Chronic Heart Failure and Lipidology
1 148 149 150 151 152 157
Filter by speciality
Remove filters

Popular this week
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#